WASHINGTON, Nov. 3 /PRNewswire-USNewswire/ -- The American Society of
Hematology, the world's largest professional society of blood specialists,
welcomes five new officers to its Executive Committee, the governing body of
the organization. The officers will begin serving their terms in January 2010.
Armand Keating, MD, will serve a one-year term as vice-president, followed by
successive terms as president-elect and president. New councillors Marilyn J.
Telen, MD, and Kenneth C. Anderson, MD, will serve four-year terms, and
Mohandas Narla, DSc, will serve as councillor for a one-year term. These
individuals are well-respected hematologists and active members of the
Society.
Dr. Keating is Professor of Medicine and Director, Division of Hematology,
Epstein Chair in Cell Therapy and Transplantation, University of Toronto, and
Director, Cell Therapy Program, Princess Margaret Hospital, Toronto. His
clinical and research interests focus on anti-cancer cell therapy, blood and
marrow transplantation, leukemia, lymphoma, and cell-based tissue
regeneration. He has conducted laboratory, translational, and clinical
research in cell therapy, normal and leukemic hematopoiesis, and the biology
and clinical application of mesenchymal stromal cells.
Dr. Telen, Wellcome Professor of Medicine and Chief, Division of Hematology,
Duke University Medical Center, is recognized as an expert in the biochemistry
and molecular genetics of blood group antigens and the pathophysiological
mechanisms of vaso-occlusion in sickle cell disease. She is the director of
the Duke Comprehensive Sickle Cell Center.
Dr. Anderson, Kraft Family Professor of Medicine, Harvard Medical School,
Dana-Farber Cancer Institute (DFCI), is Chief of the Division of Hematologic
Neoplasia, Director of the Lipper Myeloma Center and Lebow Institute for
Myeloma Therapeutics, and Vice Chair of the Joint Program in Transfusion
Medicine at DFCI. His area of research is novel biologically based therapies
for multiple myeloma.
Dr. Narla, Vice President for Research, New York Blood Center, is the Director
of the Lindsley F. Kimball Research Institute and heads the Laboratory of Red
Cell Physiology at New York Blood Center. His primary research focus is the
study of the structural organization of blood cell membranes in health and
disease and on regulation of blood cell production.
Reporters who wish to arrange an interview may contact Patrick C. Irelan, ASH
Communications Assistant, at 202-776-0544 or pirelan@hematology.org.
The American Society of Hematology (www.hematology.org) is the world's largest
professional society concerned with the causes and treatment of blood
disorders. Its mission is to further the understanding, diagnosis, treatment,
and prevention of disorders affecting blood, bone marrow, and the immunologic,
hemostatic, and vascular systems, by promoting research, clinical care,
education, training, and advocacy in hematology. ASH provides Blood: The Vital
Connection (www.bloodthevitalconnection.org), a credible online resource
addressing bleeding and clotting disorders, anemia, and cancer. The official
journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed
publication in the field, which is available weekly in print and online.
SOURCE American Society of Hematology
Patrick C. Irelan of the American Society of Hematology, +1-202-776-0544,
pirelan@hematology.org
